This randomized controlled trial compared the efficacy of a nasal mask versus a standard nasal cannula for oxygen delivery during gastrointestinal endoscopic procedures performed under target controlled propofol infusion anesthesia with SedLine brain function monitoring. Hypoxemia during procedural sedation is a common and clinically relevant event, especially during upper endoscopy and combined procedures. The study aimed to determine whether nasal mask oxygenation reduces hypoxemia compared with nasal cannula oxygenation when sedation depth is guided with electroencephalography based monitoring. Eligible adult patients undergoing gastrointestinal endoscopic procedures were randomly assigned to receive oxygen either via a nasal mask or via a nasal cannula. Oxygen was administered at a fixed flow rate according to the study protocol. Sedation was provided with target controlled propofol infusion, and SedLine monitoring was used to guide sedation depth throughout the procedure. The primary outcome was the occurrence of hypoxemia, defined as peripheral oxygen saturation at or below 90 percent. Secondary outcomes included severe hypoxemia, duration of hypoxemia, lowest peripheral oxygen saturation value, need for airway interventions, other adverse events during the procedure, procedure time, recovery time, and operator satisfaction ratings. The study has been completed.
This study was a prospective randomized controlled trial designed to compare two oxygen delivery approaches during gastrointestinal endoscopic procedures performed under target controlled propofol infusion anesthesia with SedLine brain function monitoring. The main objective was to evaluate whether nasal mask oxygenation provides better protection against hypoxemia than standard nasal cannula oxygenation when sedation depth is actively guided with electroencephalography based monitoring. Adult patients scheduled for gastrointestinal endoscopic procedures were assessed for eligibility and enrolled after appropriate ethical approval and informed consent procedures in accordance with local regulations. Participants were randomly assigned to one of two groups. In the nasal mask group, oxygen was delivered using a nasal mask device. In the nasal cannula group, oxygen was delivered using a standard nasal cannula. Oxygen flow was administered as specified in the protocol. Sedation for all patients was provided with target controlled propofol infusion. SedLine brain function monitoring was used to guide and standardize sedation depth during the procedure to reduce variability related to over sedation or under sedation. The primary outcome was hypoxemia, defined as peripheral oxygen saturation at or below 90 percent. Secondary outcomes included severe hypoxemia, duration of hypoxemia, the minimum peripheral oxygen saturation recorded, need for airway support or rescue interventions, procedure related adverse events such as cough, hiccup, nausea, vomiting, reflux, aspiration, and laryngospasm, total procedure time, recovery time, and satisfaction ratings by the anesthesiologist and the endoscopist. All outcomes were assessed during the procedure and the immediate recovery period based on standardized definitions in the study protocol. The study has been completed, and the collected data are intended to support evaluation of the comparative effectiveness and safety of nasal mask versus nasal cannula oxygenation in this clinical setting.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
600
Oxygen supplementation delivered via a nasal mask at the protocol specified flow rate during the procedure.
Oxygen supplementation delivered via a standard nasal cannula at the protocol specified flow rate during the procedure.
University of Health Sciences Sultan Abdulhamid Han Training and Research Hospital
Istanbul, Turkey (Türkiye)
Hypoxemia
Occurrence of hypoxemia defined as peripheral oxygen saturation (SpO2) ≤ 90% during the procedure
Time frame: During the endoscopic procedure and immediate recovery period (from start of sedation to discharge from the recovery area).
Severe hypoxemia
SpO2 ≤ 75% at any time, or SpO2 ≤ 90% lasting ≥ 60 seconds.
Time frame: During the endoscopic procedure and immediate recovery period
Duration of hypoxemia
Total duration (seconds) with SpO2 ≤ 90%.
Time frame: During the endoscopic procedure and immediate recovery period.
Minimum SpO2
Lowest SpO2 recorded during the procedure.
Time frame: During the endoscopic procedure
Need for airway interventions
Any airway rescue or supportive intervention required (e.g., airway repositioning, jaw thrust, increased oxygen, mask ventilation, or other emergency airway management).
Time frame: During the endoscopic procedure and immediate recovery period
Procedure-related adverse events
Cough, hiccup, nausea, vomiting, reflux, aspiration, laryngospasm, and other adverse events.
Time frame: During the endoscopic procedure and immediate recovery period.
Procedure time
Total procedure duration (minutes).
Time frame: During the procedure.
Recovery time
Time from end of procedure to readiness for discharge from recovery (minutes).
Time frame: Immediately after the procedure
Satisfaction ratings
Anesthesiologist and endoscopist satisfaction assessed using a 0-100 Numeric Rating Scale, where 0 = least satisfied and 100 = most satisfied (higher scores indicate greater satisfaction)
Time frame: mmediately after the procedure, during recovery (same day).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.